Pregene
Latest round
- Series B
Last raised
- Nov 2020
Total raised
- $21M
Investors
- 5
About Pregene
Established in 2012 and based in Shenzhen, China, Pregene operates as a CAR-T drug developer that focuses on the developing of new drugs. It acquired ISO9001 quality management system certification. In March 2020, the company obtained its first implicit clinical trial approval. In July 2023, the company was listed on the New Three Board. The company mainly fused cell drug and nano antibody drugs. Products include CAR-T cell drugs, TCR-T cell injections, CAR-NK drugs, stem cell drugs, and PRG1801. CAR-T cell drug indications cover multiple therapeutic areas such as hematological tumors, solid tumors, and autoimmune diseases. TCR-T is a Class 1 therapeutic biological product used to treat unresectable, recurrent, or metastatic soft tissue sarcomas. The company generates revenue by providing fused cell drug and nano antibody drugs.
Who invested in Pregene
5 investors across 3 rounds
See all investors in Pregene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pregene
Who invested in Pregene?
Pregene has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pregene raised?
Pregene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pregene last raise money?
Pregene's most recent round on record is a Series B, in Nov 2020.
What does Pregene do?
Established in 2012 and based in Shenzhen, China, Pregene operates as a CAR-T drug developer that focuses on the developing of new drugs.
Where is Pregene headquartered?
Pregene is headquartered in Shenzhen, China.
Which VCs invest in companies like Pregene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Pregene's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Pregene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.